Trial Profile
Dimethyl fumarate and its effect on lipid metabolism in patients with relapsing-remitting Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 May 2017
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 28 Apr 2017 Results presented at the 69th Annual Meeting of the American Academy of Neurology
- 17 Nov 2016 New trial record